The Enterprise Value as of December 2025 (TTM) for Protagonist Therapeutics, Inc. (PTGX) is 5.36B

According to Protagonist Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.36B. This represents a change of 68.40% compared to the average of 3.18B of the last 4 quarters.

Protagonist Therapeutics, Inc. (PTGX) Historical Enterprise Value (quarterly & annually)

How has PTGX Enterprise Value performed in the past?

The mean historical Enterprise Value of Protagonist Therapeutics, Inc. over the last ten years is 655.11M. The current 5.36B Enterprise Value has changed 81.66% with respect to the historical average. Over the past ten years (40 quarters), PTGX's Enterprise Value was at its highest in in the September 2025 quarter at 4.13B. The Enterprise Value was at its lowest in in the March 2016 quarter at 40.22M.

Protagonist Therapeutics, Inc. (PTGX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Protagonist Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Protagonist Therapeutics, Inc. (PTGX) Average Enterprise Value

How has PTGX Enterprise Value performed in the past?

The current Enterprise Value of Protagonist Therapeutics, Inc. (PTGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Protagonist Therapeutics, Inc. (PTGX) Enterprise Value vs. Peers

How is PTGX’s Enterprise Value compared to its peers?

Protagonist Therapeutics, Inc.’s Enterprise Value is greater than Arcellx, Inc. (3.78B), greater than Alkermes plc (4.29B), greater than TG Therapeutics, Inc. (5.11B), greater than Akero Therapeutics, Inc. (4.31B), greater than Kymera Therapeutics, Inc. (4.74B), greater than Immunovant, Inc. (3.49B), greater than Viking Therapeutics, Inc. (4.26B), greater than Crinetics Pharmaceuticals, Inc. (4.44B), less than PTC Therapeutics, Inc. (5.99B), greater than NewAmsterdam Pharma Company N.V. (3.52B),

Build a custom stock screener for Protagonist Therapeutics, Inc. (PTGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Protagonist Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Protagonist Therapeutics, Inc. (PTGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Protagonist Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.